170 related articles for article (PubMed ID: 33236584)
1. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
Brikman S; Bieber A; Dori G
Isr Med Assoc J; 2020 Aug; 22(8):505-513. PubMed ID: 33236584
[TBL] [Abstract][Full Text] [Related]
2. Cytokine storm in severe COVID-19 pneumonia.
Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
[TBL] [Abstract][Full Text] [Related]
4. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
Yongzhi X
Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
6. Laboratory biomarkers and prognosis in Covid-19, where do we stand?
Israni A; Goulden CJ; Harky A
Rev Med Virol; 2021 Nov; 31(6):e2296. PubMed ID: 34516018
[No Abstract] [Full Text] [Related]
7. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
England JT; Abdulla A; Biggs CM; Lee AYY; Hay KA; Hoiland RL; Wellington CL; Sekhon M; Jamal S; Shojania K; Chen LYC
Blood Rev; 2021 Jan; 45():100707. PubMed ID: 32425294
[TBL] [Abstract][Full Text] [Related]
8. Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives.
Ruscitti P; Giacomelli R
Isr Med Assoc J; 2020 Aug; 22(8):516-518. PubMed ID: 33236586
[TBL] [Abstract][Full Text] [Related]
9. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
Agbuduwe C; Basu S
Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
[TBL] [Abstract][Full Text] [Related]
10. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
[TBL] [Abstract][Full Text] [Related]
11. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
Hakim NN; Chi J; Olazagasti C; Liu JM
Exp Biol Med (Maywood); 2021 Jan; 246(1):5-9. PubMed ID: 32972235
[TBL] [Abstract][Full Text] [Related]
12. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
Hong R; Zhao H; Wang Y; Chen Y; Cai H; Hu Y; Wei G; Huang H
Bone Marrow Transplant; 2021 Mar; 56(3):570-580. PubMed ID: 32943758
[TBL] [Abstract][Full Text] [Related]
13. Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children.
Aydın F; Çelikel E; Ekici Tekin Z; Coşkun S; Sezer M; Karagöl C; Kaplan MM; Tekgöz N; Kurt T; Özcan S; Kavurt AV; Özkaya Parlakay A; Çelikel Acar B
Int J Rheum Dis; 2021 Apr; 24(4):542-547. PubMed ID: 33550678
[TBL] [Abstract][Full Text] [Related]
14. REPORT- Varying pattern of blood gases, ferritin, procalcitonin, C-Reactive protein, interleukin 6 and lactate dehydrogenase in Covid-19 patients suffering from diverse Co-Morbid, suspected cytokine storm and periodic effects of antiviral and steroidal treatments.
Mahmood Alam J; Asghar SS; Ali H; Mahmood SR; Ansari MA
Pak J Pharm Sci; 2021 Nov; 34(6):2265-2271. PubMed ID: 35034890
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.
Fardet L; Galicier L; Lambotte O; Marzac C; Aumont C; Chahwan D; Coppo P; Hejblum G
Arthritis Rheumatol; 2014 Sep; 66(9):2613-20. PubMed ID: 24782338
[TBL] [Abstract][Full Text] [Related]
16. Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome.
Beraud M; Hashami SA; Lozano M; Bah A; Keith P
Transfus Apher Sci; 2022 Aug; 61(4):103433. PubMed ID: 35341691
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of clinical and laboratory parameters associated with increased severity among COVID-19 patients.
Mehta AA; Haridas N; Belgundi P; Jose WM
Diabetes Metab Syndr; 2021; 15(2):535-541. PubMed ID: 33711574
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of continuous renal replacement therapy in critical COVID-19 patients with cytokine release syndrome: a retrospective, multicenter, descriptive study from Wuhan, China.
Xiang H; Song B; Zhang Y; Zhang J; Xiong J
Aging (Albany NY); 2021 Apr; 13(7):9243-9252. PubMed ID: 33811755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
